Lee Jennifer Kayden sold RYTM
August 13, 2026 · Form 4 insider transaction
Lee Jennifer Kayden sold 75,834 shares of Rhythm Pharmaceuticals, Inc. at $117.38 per share, a transaction worth $8.90M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
75,834
Price
$117.38
Total value
$8.90M
InsiderLee Jennifer Kayden
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 13, 2026
Filing dateAugust 14, 2026
Shares owned after0
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The exercises and sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2026.